Everolimus Slows Progression in Carcinoid Tumors – MedPage Today
Everolimus Slows Progression in Carcinoid TumorsMedPage TodayExplain that adding everolimus to a somatostatin analog led to improved progression-free survival among patients with advanced neuroendocrine tumors. Point out that benefits were seen in the …